Диссертация (1173320), страница 29
Текст из файла (страница 29)
Sugiyama, H. Morita [et al.] // Hypertension. – 1998. – Vol. 32, № 5. – P.935–938.189. Kauma H. Variants of renin-angiotensin system genes and echocardiographic leftventricular mass / H. Kauma, M. Ikäheimo, M.J. Savolainen [et al.] // Eur. Heart.
J. –1998. – Vol. 19, № 7. – P. 1109–1117.190. Kearney P.M. Global burden of hypertension: analysis of worldwide data /P.M. Kearney, M. Whelton, K. Reynolds [et al.] // Lancet. –2005. – Vol. 365. –P.217-223.191. Kjeldsen SE. No evidence for a J-shaped curve in treated hypertensive patientswith increased cardiovascular risk: The VALUE trial / SE. Kjeldsen, E. Berge, S.Bangalore [et al.] // Blood Press. – 2016. – Vol. 25–P. 83-92.192. Kupari M. Associations between human aldosterone synthase (CYP11B2) genepolymorphism and left ventricular size, mass and function / M.
Kupari, A. Hautanen,L. Lankinen [et al.] // Circulation. – 1998. – Vol. 97, № 6. – Р.569–575.190193. Kuznetsovа T. Left ventricular mass in relation to genetic variation in angiotensinII receptors, rennin system genes, and sodium excretion / T. Kuznetsovа, J.A.Staessen [et al.] // Circulation. – 2004. –V. 110 (17). – P. 2644-2650.194. Le Hello C.
Contribution of deletion in angiotensin-converting enzyme but notA1166C angiotensin II type-1 receptor gene polymorphisms to clinical outcomes inatherothrombotic disease / C. Le Hello, S. Fradin, R. Morello [et al.] // Archives ofMedical Research. – 2011. – Vol. 42(3). – P. 202–210.195. Levy D. Genome scan linkage results for longitudinal blood pressure phenotypesin subjects from the Framingham Heart Study / D. Levy, A.L. Destefano,M.G. Larson [et al.] // Hypertension.
– 2000. – Vol. 36 (4). – P. 477–483.196.Li J. Association of eNOS gene polymorphisms with essential hypertension inthe Han population in southwestern China / J. Li, Y. Cun, W.R. Tang [et al.] //Genet. Mol. Res. – 2011. – Vol. 10, № 3. – P.
2202-2212.197.Liu K. Alpha-adducin GLY460TRP polymorphism and essential hypertensionrisk: A meta-analysis of 22 studies including 14303 cases and 15961 controls. / K.Liu, J. Liu [et al.] PLoS ONE. – 2010. – Vol. 5, № 9. – P. e13057.198. Major outcomes in high–risk hypertensive patients randomized to angioten-sin–converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid–Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) // JAMA.
– 2002. - Vol. 288. - Р. 2981–2997.199. Mancia G. Cardiovascular outcomes at different on- treatment blood pressures inthe hypertensive patients of the VALUE trial / G. Mancia, SE. Kjeldsen, DH. Zappe[et al.] // Eur. Heart J. – 2016. – Vol. 37 – P. 955-964.200. Mancia G.Management of Arterial Hypertension of the European Society ofHypertension; European Society of Cardiology / G. Mancia [et al.] // J. Hypertens. –2007. – Vol. 25.
– P. 1105-1187.201. Manunta P. Adducin polymorphisms and the treatment of hypertension / P.Manunta, L. Citterio, C. Lanzani, M. Ferrandi // Pharmacogenomics. – 2007. – Vol.8, № 5. – P. 465-472.191202. Matthew R. Opportunities for cardiovascular risk reduction with angiotensin IIreceptor blockers / R. Matthew, M.D. Weir // Current Hypertension Reports. – 2002.– № 4. – P. 333–335.203. Mondry A. Polymorphisms of the insertion/deletion ACE and M235T AGT genesand hypertension: surprising new findings and meta-analysis / A. Mondry, M. Loh,P. Liu, A.L.
Zhu, M. Nagel // BMC Nephrol. – 2005. – Vol. 6, № 1. – P. 1-11.204. Motawi T. Endothelial nitric oxide synthase and angiotensinogen genepolymorphism in coronary artery diseases in Egypt / T. Motawi, O. Shaker, M. Taha[et al.] // Angiology. – 2011. – Vol. 62, № 2. – Р.191–197.205. Mustafina O.E. Association of the T174M polymorphism of the angiotensinogengene with essential hypertension in russian and tatars from from Bashkortostan /O.E. Mustafina, T.R. Nasibullin, E.K. Khusnutdinova // Молекулярная биология.– 2002. – Т.
36, № 4. – С.599-604.206. Nilsson P. M. The early life origins of vascular ageing and cardiovascular risk:the EVA syndrome [review] / P. M. Nilsson, E. Lurbe, S. Laurent // Hypertension. –2008. – Vol. 26. – P. 1049 -1057.207. Niu W.Q. Lack of association between alpha- adducin G460W polymorphism andhypertension: evidence from a case-control study and a meta-analysis / W.Q. Niu, Y.Zhang, K.D. Ji [et al.] // J. Hum Hypertension. – 2010. – Vol. 24 (7). – P.
467-74.208.Norton G.R. Gene variants of the rennin-angiotensin system and hypertension:from a trough of disillusionment to a welcome phase of enlightenment? / G.R.Norton, R. Brooksbank, A.J. Woodiwiss // Journal Clinical Science. – 2010. – Vol.118, № 8. – P. 487-506.209. Ortlepp J. Relation between the angiotensinogen (AGT) M235T genepolymorphism and blood pressure in a large, homogeneous study population / J.Ortlepp, J.
Metrikat, V. Mevissen [et al.] //J. Human Hypertension. – 2003. – 17 (8).– P. 555-9.210. Pereira A.C. Angiotensinogen 235 allele ―dosage‖ is associated with bloodpressure phenotypes / A.C. Pereira, J.G. Mill, R.S. Cunha [et al.] // Hypertension. –2003. – 41 (1). – P. 25-30.192211. Pibrow A.P. Angiotensinogen M235 T and T174M gene polymorphisms incombin ation doubles the risk of mortality in heart failure / A.P.
Pibrow, B.R.Palmer, C.M. Frampton [et al.] // Hypertension. – 2007. –Vol. 49, № 2. – P. 322327.212. Pilia G. Heritability of cardiovascular and personality traits in 6,148 Sardinians /G. Pilia, W.M Chen, A. Scuteri, M. Orrú [et al.] // PLoS Genetics. – 2006. – Vol.2(8). – P. 32.213. Poch E. G-protein beta (3) subunit gene variant and left ventricular hypertrophyin essential hypertension / E. Poch, D.
Gonzalez, E. Gomez-Angelats [et al.] //Hypertension. – 2000. – Vol. 35, № 1. – P. 214–218.214. PROGRESS Colaborative Study Group. Randomized trial of perindopril basedblood pressure –lowering regimen among 6108 among individuals with previousstroke or transient ischaemic attak // Lancet.
– 2001. – Vol. 358. – P. 1033-1041.215. Province M.A. Association between the α-adducin gene and hypertension in theHyperGEN Study / M.A. Province, D.K. Arnett, S.C. Hunt [et al.] // AmericanJournal of Hypertension. – 2000. – Vol. 13. – № 6. – P.
710—718.216. Reshetnikov E. The insertion-deletion polymorphism of the ACE gene isassociated with increased blood pressure in women at the end of pregnancy / E.Reshetnikov,L.Y. Akulova [et al.] // J. of the Renin-Angiotensin-AldosteroneSystem. – 2015. –Vol. 16, № 3. – P. 623-632217.Rijn M.J. Heritability of blood pressure traits and the genetic contribution toblood pressure variance explained by four blood pressure-related genes / M.J.
Rijn,A.F. Schut, Y.S. Aulchenko [et al.] // J. Hypertens. – 2007. – Vol. 25(3). – P. 565–570.218. Rossi G.P. The T-786C and Glu298Asp polymorphisms of the endothelial nitricoxide gene affect the forearm blood flow responses of Caucasian hypertensivepatients / G.P. Rossi, S. Taddei, A.
Virdis [et al.] // J. Amer. Coll. Cardiology. –2003. – Vol. 41. – P. 938-945.219.Sabban E.L. Catecholamines in stress: molecular mechanisms of gene expression/ E.L. Sabban // Endocrine Regul. –2007. –Vol. 41. – P. 61–73.193220.Schmieder R.E. Effect of the Angiotensin II type 2-Receptor Gene (+1675 G/A)on Left Ventricular Structure in Humans / R.E. Schmieder, J. Erdmann, C. Delles [etal.] // J. Am. Coll. Cardiol. – 2001.
– Vol. 37, № 1. – P. 175–182.221. Schunkert H. Lack of association between a polymorphism of the aldosteronesynthase gene and left ventricular structure / H. Schunkert, C. Hengstenberg, S.R.Holmer [et al.] // Circulation. – 1999. – Vol. 99, № 17. – P. 2255–2260.222. Sethi A.A. Angiotensinogen single nucleotide polymorphisms, elevated bloodpressure, and risk of cardiovascular disease / A.A. Sethi, B.G. Nordestgaard, M.L.Grønholdt, R. Steffensen [et al.] // Hypertension. – 2003. – Vol.
41, № 6. – P. 12021211.223. Shlyakhto E.V. Lack of Association of the Renin-angiotensin System GenesPolymorphisms and Left Ventricular Hypertrophy in Hypertension / E.V. Shlyakhto,E.I. Shwartz, Y.B. Neferova [et al.] // Blood Pressure. – 2001. – Vol. 10, № 3. – P.135–141.224. Siffert W. Association of a human G protein beta3 subunit variant withhypertension / W.
Siffert, D. Rosskopf, G. Siffert [et al.] // Nat. Genet. – 1998. 18(1). – P. 45–48.225. Takami S. Angiotensin II type1 receptor gene polymorphism is associated withincrease of left ventricular mass but not with hypertension / S. Takami, T. Katsuya,H. Rakugi [et al.] // Am.
J. Hypertens. – 1998. – Vol. 11, № 3. – P. 316–321.226. The heart outcomers prevention evaluations study investigators/ Effects angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high –risk patients // New Engl. J. Med. – 2000. – Vol. 342. – P. 145-153.227.Tobin M.D. Association of WNK1 gene polymorphisms and haplotypes withambulatory blood pressure in the general population / M.D. Tobin, S.M. Raleigh, S.Newhouse [et al.] // Circulation. – 2005.
– Vol. 112 (22). – Р. 3423–3429.228. Valeur N. The prognostic value of pre-discharge exercise testing after myocardialinfarction treated with either primary PCI or fybrinolysis: a DAMAMI-2 sub-study /N. Valeur, P. Clemmensen, K. Saunamaki [et al.] // European Heart Journal.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
